The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients
Waleed Albaker,1 Mona Al Sheikh,2 Aishah Albakr,3 Dania Alkhafaji,1 Eman Al Besher,4 Mohammed Al-Hariri2 1Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 2Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal Un...
Guardado en:
Autores principales: | Albaker W, Al Sheikh M, Albakr A, Alkhafaji D, Al Besher E, Al-Hariri M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d4b22a63b744e2a91bd77541eb7cbf6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Impact of Liraglutide as a Treatment of Obesity
por: Alruwaili H, et al.
Publicado: (2021) -
Weight loss medications in Canada – a new frontier or a repeat of past mistakes?
por: Wharton S, et al.
Publicado: (2017) -
Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved
por: Liesbet Trenson, et al.
Publicado: (2021) -
Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day
por: Igor A. Sklyanik, et al.
Publicado: (2021) -
Assessment of noise levels in 200 Mosques in Riyadh, Saudi Arabia
por: S A Al Shimemeri, et al.
Publicado: (2011)